Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 30, 2019	Nov. 30, 2018
Cash flows from operating activities:
Net loss	$ (8,169)	$ (14,485)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	9,897	8,811
Amortization of debt discount	617	616
Intangible asset impairment charge		9,814
Bad debt expense	303	372
(Gain) loss on forward contracts	(347)	132
Equity in income of equity investees	(3,672)	(5,146)
Distribution of income from equity investees	4,169	4,899
Deferred income tax (benefit) expense	(338)	2,606
Non-cash compensation adjustment	(51)	(840)
Stock based compensation expense	1,816	393
Impairment of Venezuela investment properties		3,473
(Gain) loss on sale of property, plant and equipment	(3,788)	15
Changes in operating assets and liabilities:
Accounts receivable	(20,880)	(5,709)
Inventory	(9,353)	(2,648)
Receivables from vendors	790	24
Prepaid expenses and other	528	4,549
Investment securities-trading	304	903
Accounts payable, accrued expenses, accrued sales incentives and other liabilities	3,379	4,159
Income taxes payable	908	(1,833)
Net cash (used in) provided by operating activities	(23,887)	10,105
Cash flows used in investing activities:
Purchases of property, plant and equipment	(2,192)	(4,084)
Proceeds from sale of property, plant and equipment	11,951	47
Issuance of notes receivable		(4,931)
Net cash provided by (used in) investing activities	9,759	(8,968)
Cash flows used in financing activities:
Principal payments on finance lease obligation	(477)	(295)
Repayment of bank obligations	(9,046)	(1,870)
Borrowings on bank obligations		1,974
Purchase of treasury stock	(2,040)
Net cash used in financing activities	(11,563)	(191)
Effect of exchange rate changes on cash	(389)	(3,968)
Net decrease in cash and cash equivalents	(26,080)	(3,022)
Cash and cash equivalents at beginning of period	58,236	51,740
Cash and cash equivalents at end of period	$ 32,156	$ 48,718